Announcements Trials
Browse Landscape

Phase

Phase 1 9Phase 2 4Phase 3 3Phase 1/2 2Phase 2/3 1

Status

Completed 27Unknown 8Terminated 5Active not recruiting 5Recruiting 4Not yet recruiting 3Withdrawn 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 3NET 1Endocrine 1

Conditions

Ras-mutated Metastatic Colorectal Cancer 1Pancreatic Adenocarcinoma Metastatic 1Neuroendocrine Tumors 1Colorectal Neoplasms 1Colonic Neoplasms 1

Interventions

pembrolizumab 223Carboplatin 222Specimen Handling 194Cisplatin 192Magnetic Resonance Spectroscopy 165Radiotherapy 153Bevacizumab 143Gemcitabine 136Cyclophosphamide 135Drug Therapy 119Capecitabine 118Paclitaxel 116Oxaliplatin 111Nivolumab 105Biopsy 104venetoclax 103tislelizumab 83Rituximab 83durvalumab 82toripalimab 78Fluorouracil 73Etoposide 72Docetaxel 69Dexamethasone 69sintilimab 67Pemetrexed 67atezolizumab 65Radiosurgery 65Azacitidine 63130-nm albumin-bound paclitaxel 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × IFL protocol × Clear all
NCT07446322 2026-05-05

FOLFIRI and Bevacizumab With or Without Pelareorep for Second-Line Treatment of Metastatic RAS-Mutated, Microsatellite-Stable Colorectal Cancer

Oncolytics Biotech

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Ras-mutated Metastatic Colorectal Cancer

NCT06747845 2025-09-16

ParpVax2

Abramson Cancer Center at Penn Medicine

Phase 2 Recruiting
68 enrolled
Gastrointestinal

Pancreatic Adenocarcinoma Metastatic

NCT06640166 2025-02-12

ECLYPse

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 2 Recruiting
25 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT05879055 2024-12-19

A Study of PM8002 in Combination With Chemotherapy in Patients With NEN

Biotheus Inc.

Phase 2 Recruiting
60 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡